Standardized protocol for quantification of nerve bundle density as a biomarker for endometriosis

Introduction We propose a standardized protocol for measurement of nerve bundle density in endometriosis as a potential biomarker, including in deep endometriosis (DE), ovarian endometriomas (OMA) and superficial peritoneal endometriosis (SUP). Methods This was a prospective cohort of surgically excised endometriosis samples from Dec 1st 2013 and Dec 31st 2017 at a tertiary referral center for endometriosis in Vancouver, BC, Canada. Surgical data were available from linked patient registry. Protein gene product 9.5 (PGP9.5) was used to identify nerve bundles on immunohistochemistry. PGP9.5 nerve bundles were counted visually. To calculate nerve bundle density, PGP9.5 nerve bundle count was divided by the tissue surface area (total on the slide). All samples were assessed using NHS Elements software for semi-automated measurement of the tissue surface area. For a subset of samples, high power fields (HPFs) were also counted as manual measurement of the tissue surface area. Intraclass correlation was used to assess intra observer and inter observer reliability. Generalized linear mixed model (GLMM) with random intercepts only was conducted to assess differences in PGP9.5 nerve bundle density by endometriosis type (DE, OMA, SUP). Results In total, 236 tissue samples out of 121 participants were available for analysis in the current study. Semi-automated surface area measurement could be performed in 94.5% of the samples and showed good correlation with manually counted HPFs (Spearman's rho = 0.781, p < 0.001). To assess intra observer reliability, 11 samples were assessed twice by the same observer; to assess inter observer reliability, 11 random samples were blindly assessed by two observers. Intra observer reliability and inter observer reliability for nerve bundle density were excellent: 0.979 and 0.985, respectively. PGP9.5 nerve bundle density varied among samples and no nerve bundles could be found in 24.6% of the samples. GLMM showed a significant difference in PGP9.5 nerve bundle density between the different endometriosis types (X2 = 87.6, P < 0.001 after adjusting for hormonal therapy, with higher density in DE and SUP in comparison to OMA). Conclusion A standardized protocol is presented to measure PGP9.5 nerve bundle density in endometriosis, which may serve as a biomarker reflecting local neurogenesis in the endometriosis microenvironment.

[1]  M. Anglesio,et al.  Neuroproliferative dyspareunia in endometriosis and vestibulodynia. , 2023, Sexual medicine reviews.

[2]  J. Senz,et al.  KRAS mutations and endometriosis burden of disease , 2023, The journal of pathology. Clinical research.

[3]  S. Missmer,et al.  Pathophysiology, diagnosis, and management of endometriosis , 2022, BMJ.

[4]  Pratibha Singh,et al.  Detection of nerve fibers in the eutopic endometrium of women with endometriosis, uterine fibroids and adenomyosis , 2021, Obstetrics & gynecology science.

[5]  C. Allaire,et al.  A Proposed Platform for Phenotyping Endometriosis-Associated Pain: Unifying Peripheral and Central Pain Mechanisms , 2020, Current Obstetrics and Gynecology Reports.

[6]  K. Zondervan,et al.  Endometriosis. , 2020, The New England journal of medicine.

[7]  J. Donnez,et al.  Invasion of human deep nodular endometriotic lesions is associated with collective cell migration and nerve development. , 2018, Fertility and sterility.

[8]  K. Zondervan,et al.  Risk for and consequences of endometriosis: A critical epidemiologic review. , 2018, Best practice & research. Clinical obstetrics & gynaecology.

[9]  M. Bedaiwy,et al.  Nerve Growth Factor Is Associated With Sexual Pain in Women With Endometriosis , 2018, Reproductive Sciences.

[10]  C. Allaire,et al.  An Interdisciplinary Approach to Endometriosis-associated Persistent Pelvic Pain , 2017 .

[11]  C. Allaire,et al.  Multifactorial contributors to the severity of chronic pelvic pain in women. , 2016, American journal of obstetrics and gynecology.

[12]  I. Fraser,et al.  Nerve Bundles and Deep Dyspareunia in Endometriosis , 2016, Reproductive Sciences.

[13]  G. B. Buck Louis,et al.  Pain typology and incident endometriosis. , 2015, Human reproduction.

[14]  I. Fraser,et al.  Use of hormonal therapy is associated with reduced nerve fiber density in deep infiltrating, rectovaginal endometriosis , 2015, Acta obstetricia et gynecologica Scandinavica.

[15]  K. Zondervan,et al.  Central changes associated with chronic pelvic pain and endometriosis. , 2014, Human reproduction update.

[16]  A. Ebert,et al.  Influence of Nerve Growth Factor in Endometriosis-Associated Symptoms , 2011, Reproductive Sciences.

[17]  Cai-yun Zhou,et al.  Nerve fibres in ovarian endometriotic lesions in women with ovarian endometriosis. , 2010, Human reproduction.

[18]  A. Ebert,et al.  A pilot study to evaluate the clinical relevance of endometriosis-associated nerve fibers in peritoneal endometriotic lesions. , 2009, Fertility and sterility.

[19]  I. Fraser,et al.  Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis. , 2009, Fertility and sterility.

[20]  I. Fraser,et al.  Rich innervation of deep infiltrating endometriosis. , 2008, Human reproduction.

[21]  R. Smego,et al.  An academic health center‐community partnership: the Morgantown Health Right free clinic , 1996, Academic medicine : journal of the Association of American Medical Colleges.